Get the Stockscreener App
9.70
3.39%
-0.34
After Hours:
9.70
Organon Co stock is traded at $9.70, with a volume of 4.76M.
It is down -3.39% in the last 24 hours and up +0.21% over the past month.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
See More
Previous Close:
$10.04
Open:
$10.01
24h Volume:
4.76M
Relative Volume:
0.88
Market Cap:
$2.52B
Revenue:
$6.29B
Net Income/Loss:
$750.00M
P/E Ratio:
3.3681
EPS:
2.88
Net Cash Flow:
$586.00M
1W Performance:
-3.67%
1M Performance:
+0.21%
6M Performance:
-37.66%
1Y Performance:
-55.63%
1-Day Range:
$9.65
$10.04
1-Week Range:
$9.65
$10.39
52-Week Range:
$8.01
$23.10
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
9.70 | 2.61B | 6.29B | 750.00M | 586.00M | 2.88 |
|
LLY
Lilly Eli Co
|
740.07 | 682.35B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
164.74 | 402.82B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
189.02 | 334.40B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
113.74 | 225.78B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
78.12 | 205.28B | 63.62B | 16.41B | 17.04B | 6.49 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
OGN’s Market Whiplash: -54.75% YTD Decline, 3.72% Rise in 30 Days - investchronicle.com
Organon & Co (OGN.US) will release its Earnings Reports before the market opens on August 5th. - 富途牛牛
Can Analyst Optimism Outweigh Softer Earnings Expectations for Organon (OGN) This Quarter? - simplywall.st
Ramsay Health Care (OTCMKTS:RMYHY) vs. Organon & Co. (NYSE:OGN) Head to Head Contrast - Defense World
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Envestnet Asset Management Inc. Has $4.51 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World
Organon & Co. (NYSE:OGN) versus Enhabit (NYSE:EHAB) Head-To-Head Comparison - Defense World
Global Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - Yahoo Finance
Mutual of America Capital Management LLC Reduces Position in Organon & Co. (NYSE:OGN) - Defense World
Organon & Co. Investors: Please contact the Portnoy Law - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming DeadlinesOGN - PR Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - Business Wire
Organon & Co. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your RightsOGN - MarketScreener
ORGANON FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025 - Business Wire
Organon Financial Results: Q2 2025 Earnings Call Set for August 5 Pre-Market - Stock Titan
Organon & Co. (OGN) Stock Analysis: Evaluating the 48% Potential Upside Amidst Current Challenges - DirectorsTalk Interviews
Securities Lawsuit Alert: Organon & Co. (OGN)Contact Levi & Korsinsky Before July 22, 2025 - Newsfile
The Gross Law Firm Notifies Organon & Co. Investors of a Class Action Lawsuit and Upcoming Deadline – OGN - GlobeNewswire
July 22, 2025 Deadline Approaching: Join Class Action Against Organon & Co. (OGN)Contact Levi & Korsinsky - ACCESS Newswire
Organon & Co. (OGN) Restructures, Expands in Women’s Health and Biosimilars - MSN
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
UPDATEDaré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - GlobeNewswire Inc.
Deadline Soon: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - The Globe and Mail
Organon & Co. (OGN) LawsuitInvestors Urged to Contact Levi & Korsinsky Before July 22, 2025 - The Globe and Mail
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
The Gross Law Firm Notifies Shareholders of Organon & Co.(OGN) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
ORGANON & CO. (NYSE: OGN) SHAREHOLDER ALERT Bernstein - GlobeNewswire
INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd - GlobeNewswire
Xponance Inc. Has $206,000 Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World
Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025Contact Levi & Korsinsky - Stockhouse
Lost Money on Organon & Co. (OGN)? Contact Levi & Korsinsky to Join Class Action Before July 22, 2025 - ACCESS Newswire
OGN SECURITIES NEWS: Did Organon & Co. (NYSE:OGN) Commit - GlobeNewswire
Organon & Co. (OGN): Navigating Legal Deadlines and Market Volatility in a Securities Class Action - AInvest
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - GlobeNewswire
Class Action Filed Against Organon & Co. (OGN) Over Securities ViolationsContact Levi & Korsinsky Today - Stockhouse
OGN DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, - GlobeNewswire
ORGANON DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon - StreetInsider
TUESDAY INVESTOR DEADLINE: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
ORGANON 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Organon & Co.OGN - FinancialContent
Organon (OGN) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Deadline Alert: Organon & Co. (OGN) Investors Who Lost - GlobeNewswire
The Gross Law Firm Reminds Organon & Co. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025OGN - Barchart.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming DeadlinesOGN - FinancialContent
OGN SECURITIES FRAUD: Organon & Co. (NYSE:OGN) 27% Stock - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Organon & Co.(OGN) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):